Study Comparing Tension-free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence
- Conditions
- Stress Urinary Incontinence
- Interventions
- Device: Tension-free Vaginal TapeDevice: Monarc sub-fascial hammock
- Registration Number
- NCT00475839
- Lead Sponsor
- The Cleveland Clinic
- Brief Summary
Urinary incontinence is a major health issue in women. It is estimated to affect 30 - 40% of older women. Stress urinary incontinence, the most common form of this disease, is treated primarily with surgery. A woman's lifetime risk of surgery for SUI is 4%, with nearly 1/3 of surgery being performed for recurrences. Many different surgical procedures have been described for the treatment of SUI and there is no general agreement as to the most effective. This study compares the safety and efficacy of the tension-free vaginal tape procedure to the Monarc subfascial hammock procedure in the treatment of stress urinary incontinence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 180
- Urinary incontinence symptoms
- Urodynamic stress incontinence confirmed with multichannel urodynamic testing
- Age of at least 21 years
- Desires surgical correction of stress urinary incontinence
- Post-void residual volume >100cc
- Detrusor overactivity on preoperative multichannel urodynamic testing
- History of previous synthetic, biologic or fascial sub-urethral sling
- Desires future childbearing
- Chronic inguinal or vulvar abscess or history of Hidradenitis Suppurativa
- History of bleeding diathesis or current anti-coagulation therapy
- Inguinal lymphadenopathy or inguinal/vulvar mass
- Current genitourinary fistula or urethral diverticulum
- Reversible cause of incontinence (i.e. drug effect)
- Contraindication to surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tension-free Vaginal Tape Tension-free Vaginal Tape - Monarc Sub-fascial hammock Monarc sub-fascial hammock -
- Primary Outcome Measures
Name Time Method The presence of abnormal bladder function, defined as the sign or symptom of urinary incontinence or urinary retention 12 months
- Secondary Outcome Measures
Name Time Method Complications Postoperative pain 2 weeks, 6 weeks HRQOL 6 months, 12 months, 18 months, 24 months Sexual function 12 months, 24 months Global improvement in bladder function 6 months, 12 months, 18 months, 24 months Development of anterior vaginal prolapse 12 months, 24 months
Trial Locations
- Locations (3)
Cleveland Clinic
🇺🇸Cleveland, Ohio, United States
Greater Baltimore Medical Center
🇺🇸Baltimore, Maryland, United States
Good Samaritan Hospital
🇺🇸Cincinnati, Ohio, United States